FHA
CLBT icon

First Horizon Advisors’s Cellebrite CLBT Stock Holding History

First Horizon Advisors’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$6.21K Buy
388
+361
+1,337% +$6.43K ﹤0.01% 1802
2025
Q1 		$523 Buy
+27
New +$568 ﹤0.01% 2207

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
AE
Axon Enterprise Scottsdale, Arizona $18.1M AUM 29.08% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

First Horizon Advisors's CLBT Position: Q2 2025 in Review

First Horizon Advisors increased its Cellebrite (CLBT) stake by 1,337% in Q2 2025, buying an estimated $6.43K and bringing the position to 388 shares worth $6.21K. The position accounts for ﹤0.01% of the portfolio, ranked #1802.

First Horizon Advisors first reported a position in CLBT in Q1 2025 and has held it in 2 quarters since. 208 funds tracked by Wall St. Rank hold CLBT as of Q2 2025.

  • First Horizon Advisors held 388 shares of Cellebrite worth $6.21K as of Q2 2025.
  • First Horizon Advisors bought 361 Cellebrite shares in Q2 2025, an estimated $6.43K.
  • Cellebrite made up ﹤0.01% of First Horizon Advisors's portfolio in Q2 2025, its #1802 holding.
  • First Horizon Advisors first reported a position in Cellebrite in Q1 2025 and has held it in 2 quarters since.
  • 208 funds tracked by Wall St. Rank held Cellebrite as of Q2 2025.

Based on First Horizon Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.